Epigenetics, stress, and their potential impact on brain network function: A focus on the schizophrenia diatheses

Frontiers in Psychiatry

Volumn 5, Issue JUN, 2014, Pages

  Diwadkar, Vaibhav A ^a   Bustamante, Angela ^a   Rai, Harinder ^a   Uddin, Monica ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescence; Brain networks; Epigenetics; Risk; Schizophrenia

Indexed keywords

ADOLESCENT DEVELOPMENT; ARTICLE; BRAIN FUNCTION; COPING BEHAVIOR; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; NEUROBIOLOGY; NONHUMAN; PSYCHOSOCIAL DEVELOPMENT; RISK FACTOR; SCHIZOPHRENIA; STRESS;

EID: 84904459179     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00071     Document Type: Article

References (158)

1. Schultz SK, Andreasen NC. Schizophrenia. Lancet (1999) 353:1425-30. doi: 10.1016/S0140-6736(98)07549-7
2. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 10:434-49.
3. Tan HY, Callicott JH, Weinberger DR. Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn Neuropsychiatry (2009) 14:277-98. doi:10.1080/13546800903091665
4. Gogtay N. Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr Bull (2008) 34:30-6. doi:10.1093/schbul/sbm103
5. Castner SA, Williams GV. Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn (2007) 63:94-122. doi:10.1016/j.bandc.2006.11.002
6. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia - all roads lead to dopamine. Eur Neuropsychopharmacol (2007) 17(Suppl 2):S101-7. doi:10.1016/j.euroneuro.2007.02.005
7. Howes OD, Murray RM. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 383(9929):1677-87. doi:10.1016/S0140-6736(13)62036-X
8. Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 11:487-508. doi:10.1017/S0954579499002175
9. Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res (2008) 103:114-20. doi:10.1016/j.schres.2008.03.006
10. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 25:409-32. doi:10.1146/annurev.neuro.25.112701.142754
11. Millan MJ. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology (2013) 68:2-82. doi:10.1016/j.neuropharm.2012.11.015
12. Keshavan MS, Diwadkar VA, Montrose DM, Rajarathinam R, Sweeney JA. Premorbid indicators of risk for schizophrenia: a selective review and update. Schizophr Res (2005) 79:45-57. doi:10.1016/j.schres.2005.07.004
13. Diwadkar VA. Adolescent risk pathways toward schizophrenia: sustained attention and the brain. Curr Top Med Chem (2012) 12:2339-47. doi:10.2174/156802612805289962
14. Diwadkar VA, Ofen N. Disordered brain network function in adolescence: impact on thought, language and vulnerability for schizophrenia. In: Brambilla P, Marini A, editors. Brain Evolution, Language and Psychopathology in Schizophrenia. Oxford: Taylor and Francis Group (2014). p. 73-95.
15. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci (1998) 840:33-44. doi:10.1111/j.1749-6632.1998.tb09546.x
16. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry (2000) 48:721-31. doi:10.1016/S0006-3223(00)00964-1
17. Petronis A, Paterson AD, Kennedy JL. Schizophrenia: an epigenetic puzzle? Schizophr Bull (1999) 25:639-55. doi:10.1093/oxfordjournals.schbul.a033408
18. Gogtay N, Rapoport JL. Childhood-onset schizophrenia: insights from neuroimaging studies. J Am Acad Child Adolesc Psychiatry (2008) 47:1120-4. doi:10.1097/CHI.0b013e31817eed7a
19. Rapoport JL, Gogtay N. Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging. Neuropsychopharmacology (2008) 33:181-97. doi:10.1038/sj.npp.1301553
20. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry (2001) 50:825-44. doi:10.1016/S0006-3223(01)01252-5
21. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 10:40-68.
22. Gottesman I, Shields J. A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophr Bull (1976) 2:360-401. doi:10.1093/schbul/2.3.360
23. Gottesman II, Shields J. Schizophrenia: The Epigenetic Puzzle. New York: Cambridge University Press (1982).
24. Lupien SJ, Ouellet-Morin I, Hupbach A, Tu MT, Buss C, Walker D, et al. Beyond the stress concept: allostatic load - a developmental biological and cognitive perspective. In: Cicchetiti DJCD, editor. Developmental Psychopathology. Hoboken, NJ: John Wiley & Sons (2006). p. 578-628.
25. Feinberg I. Cortical pruning and the development of schizophrenia. Schizophr Bull (1990) 16:567-70. doi:10.1093/schbul/16.4.567
26. Dahl RE. Adolescent brain development: a period of vulnerabilities and opportunities. Keynote address. Ann N Y Acad Sci (2004) 1021:1-22. doi:10.1196/annals.1308.001
27. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med (1993) 153:2093-101.
28. Bremner JD, Narayan M. The effects of stress on memory and the hippocampus throughout the life cycle: implications for childhood development and aging. Dev Psychopathol (1998) 10:871-85. doi:10.1017/S0954579498001916
29. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus (2001) 11:520-8. doi:10.1002/hipo.1068
30. Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry (2004) 56:101-12. doi:10.1016/j.biopsych.2004.04.002
31. Bremner JD. Effects of traumatic stress on brain structure and function: relevance to early responses to trauma. J Trauma Dissociation (2005) 6:51-68. doi:10.1300/J229v06n02_06
32. Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci (2009) 10:410-22. doi:10.1038/nrn2648
33. Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci (2004) 24:2825-31. doi:10.1523/JNEUROSCI.3422-03.2004
34. Arnsten AF. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci (2011) 29:215-23. doi:10.1016/j.ijdevneu.2011.02.006
35. Bassett DS, Bullmore E, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. Hierarchical organization of human cortical networks in health and schizophrenia. J Neurosci (2008) 28:9239-48. doi:10.1523/JNEUROSCI.1929-08.2008
36. Arnsten AF, Paspalas CD, Gamo NJ, Yang Y, Wang M. Dynamic network connectivity: a new form of neuroplasticity. Trends Cogn Sci (2010) 14:365-75. doi:10.1016/j.tics.2010.05.003
37. Banyai M, Diwadkar VA, Erdi P. Model-based dynamical analysis of functional disconnection in schizophrenia. Neuroimage (2011) 58:870-7. doi:10.1016/j.neuroimage.2011.06.046
38. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 70:107-20. doi:10.1001/jamapsychiatry.2013.269
39. Walker EF, Diforio D, Baum K. Developmental neuropathology and the precursors of schizophrenia. Acta Psychiatr Scand Suppl (1999) 395:12-9. doi:10.1111/j.1600-0447.1999.tb05978.x
40. Wood SJ, Reniers RL, Heinze K. Neuroimaging findings in the at-risk mental state: a review of recent literature. Can J Psychiatry (2013) 58:13-8.
41. Bechdolf A, Thompson A, Nelson B, Cotton S, Simmons MB, Amminger GP, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand (2010) 121:377-84. doi:10.1111/j.1600-0447.2010.01542.x
42. Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 67:241-51. doi:10.1001/archgenpsychiatry.2009.206
43. Holtzman CW, Shapiro DI, Trotman HD, Walker EF. Stress and the prodromal phase of psychosis. Curr Pharm Des (2012) 18:527-33. doi:10.2174/138161212799316280
44. Devylder JE, Ben-David S, Schobel SA, Kimhy D, Malaspina D, Corcoran CM. Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis. Psychol Med (2013) 43:259-68. doi:10.1017/S0033291712001262
45. Holtzman CW, Trotman HD, Goulding SM, Ryan AT, Macdonald AN, Shapiro DI, et al. Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (2013) 249:172-91. doi:10.1016/j.neuroscience.2012.12.017
46. Walker EF, Trotman HD, Goulding SM, Holtzman CW, Ryan AT, McDonald A, et al. Developmental mechanisms in the prodrome to psychosis. Dev Psychopathol (2013) 25:1585-600. doi:10.1017/S0954579413000783
47. Woods SW, Miller TJ, McGlashan TH. The "prodromal" patient: both symptomatic and at-risk. CNS Spectr (2001) 6:223-32.
48. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 65:28-37. doi:10.1001/archgenpsychiatry.2007.3
49. Klosterkotter J, Schultze-Lutter F, Ruhrmann S. Kraepelin and psychotic prodromal conditions. Eur Arch Psychiatry Clin Neurosci (2008) 258(Suppl 2):74-84. doi:10.1007/s00406-008-2010-5
50. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 60:21-32. doi:10.1016/S0920-9964(02)00167-6
51. Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry (2010) 67:683-91. doi:10.1001/archgenpsychiatry.2010.77
52. Benetti S, Mechelli A, Picchioni M, Broome M, Williams S, McGuire P. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain (2009) 132:2426-36. doi:10.1093/brain/awp098
53. Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, et al. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 30:4129-37. doi:10.1002/hbm.20834
54. Dauvermann MR, Whalley HC, Romaniuk L, Valton V, Owens DG, Johnstone EC, et al. The application of nonlinear dynamic causal modelling for fMRI in subjects at high genetic risk of schizophrenia. Neuroimage (2013) 73:16-29. doi:10.1016/j.neuroimage.2013.01.063
55. Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, et al. Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med (2012) 42:1835-45. doi:10.1017/S0033291711002996
56. Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 168:1311-7. doi:10.1176/appi.ajp.2011.11010160
57. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, et al. The stress cascade and schizophrenia: etiology and onset. Schizophr Bull (2003) 29:671-92. doi:10.1093/oxfordjournals.schbul.a007038
58. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Grasby PM, McGuire PK. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 51:s13-8. doi:10.1192/bjp.191.51.s13
59. Thompson KN, Phillips LJ, Komesaroff P, Yuen HP, Wood SJ, Pantelis C, et al. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res (2007) 41:561-9. doi:10.1016/j.jpsychires.2006.05.010
60. Tandon N, Montrose D, Shah J, Rajarethinam RP, Diwadkar VA, Keshavan MS. Early prodromal symptoms can predict future psychosis in familial high-risk youth. J Psychiatr Res (2012) 46:105-10. doi:10.1016/j.jpsychires.2011.09.019
61. Cannon TD, Gasperoni TL, Van Erp TG, Rosso IM. Quantitative neural indicators of liability to schizophrenia: implications for molecular genetic studies. Am J Med Genet (2001) 105:16-9. doi:10.1002/1096-8628(20010108)105:1<16::AID-AJMG1046>3.3.CO;2-Q
62. Cannon TD, Thompson PM, Van Erp TG, Toga AW, Poutanen VP, Huttunen M, et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A (2002) 99:3228-33. doi:10.1073/pnas.052023499
63. Erlenmeyer-Kimling L, Squires-Wheeler E, Adamo UH, Bassett AS, Cornblatt BA, Kestenbaugh CJ, et al. The New York high-risk project. Arch Gen Psychiatry (1995) 10:857-65. doi:10.1001/archpsyc.1995.03950220067013
64. Mednick SA, Parnas J, Schulsinger F. The Copenhagen High-Risk Project, 1962-1986. Schizophr Bull (1987) 13:485-95. doi:10.1093/schbul/13.3.485
65. Mirsky AF, Kugelmass S, Ingraham LJ, Frenkel E, Nathan M. Overview and summary: twenty-five year follow-up of high-risk children. Schizophr Bull (1995) 21:227-39. doi:10.1093/schbul/21.2.227
66. Collip D, Nicolson NA, Lardinois M, Lataster T, Van Os J, Myin-Germeys I, et al. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol Med (2011) 41:2305-15. doi:10.1017/S0033291711000602
67. Habets P, Collip D, Myin-Germeys I, Gronenschild E, Van Bronswijk S, Hofman P, et al. Pituitary volume, stress reactivity and genetic risk for psychotic disorder. Psychol Med (2012) 42:1523-33. doi:10.1017/S0033291711002728
68. Diwadkar VA, Montrose DM, Dworakowski D, Sweeney JA, Keshavan MS. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry (2006) 30:230-8. doi:10.1016/j.pnpbp.2005.10.019
69. Keshavan MS, Gilbert AR, Diwadkar VA. Developmental hypotheses of schizophrenia. In: Lieberman JA, Stroup TS, Perkins DO, editors. Textbook of Schizophrenia. Arlington, VA: American Psychiatric Publishing (2006). p. 69-84.
70. Erlenmeyer-Kimling L, Cornblatt BA. A summary of attentional findings in the New York high-risk project. J Psychiatr Res (1992) 26:405-26. doi:10.1016/0022-3956(92)90043-N
71. Diwadkar V, Sweeney J, Boarts D, Montrose D, Keshavan M. Oculomotor delayed response abnormalities in young offspring and siblings at risk for schizophrenia. CNS Spectr (2001) 6(11):899-903.
72. Cornblatt BA. The New York high risk project to the hillside recognition and prevention (RAP) program. Am J Med Genet (2002) 114:956-66. doi:10.1002/ajmg.b.10520
73. Johnstone EC, Russell KD, Harrison LK, Lawrie SMJ. The Edinburgh high risk study: current status and future prospects. World Psychiatry (2003) 2:45-9.
74. Phillips LK, Seidman LJ. Emotion processing in persons at risk for schizophrenia. Schizophr Bull (2008) 34:888-903. doi:10.1093/schbul/sbn085
75. Barbour T, Pruitt P, Diwadkar VA. fMRI responses to emotional faces in children and adolescents at genetic risk for psychiatric illness share some of the features of depression. J Affect Disord (2012) 136:276-85. doi:10.1016/j.jad.2011.11.036
76. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: hormonal mediators and human development. Horm Res (2003) 59:161-79. doi:10.1159/000069325
77. Brown GR, Spencer KA. Steroid hormones, stress and the adolescent brain: a comparative perspective. Neuroscience (2013) 249:115-28. doi:10.1016/j.neuroscience.2012.12.016
78. Bassett AS, Collins EJ, Nuttall SE, Honer WG. Positive and negative symptoms in families with schizophrenia. Schizophr Res (1993) 11:9-19. doi:10.1016/0920-9964(93)90033-F
79. Kwapil TR. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol (1998) 107:558-65. doi:10.1037/0021-843X.107.4.558
80. Diwadkar VA, Segel J, Pruitt P, Murphy ER, Keshavan MS, Radwan J, et al. Hypo-activation in the executive core of the sustained attention network in adolescent offspring of schizophrenia patients mediated by pre-morbid functional deficits. Psychiatry Res (2011) 192:91-9. doi:10.1016/j.pscychresns.2010.12.005
81. Brekke JS, Raine A, Thomson C. Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum. Psychiatry Res (1995) 57:241-50. doi:10.1016/0165-1781(95)02668-M
82. Horan WP, Brown SA, Blanchard JJ. Social anhedonia and schizotypy: the contribution of individual differences in affective traits, stress, and coping. Psychiatry Res (2007) 149:147-56. doi:10.1016/j.psychres.2006.06.002
83. Shotbolt P, Stokes PR, Owens SF, Toulopoulou T, Picchioni MM, Bose SK, et al. Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med (2011) 41:2331-8. doi:10.1017/S0033291711000341
84. Bremne JD, Vermetten E. Stress and development: behavioral and biological consequences. Dev Psychopathol (2001) 13:473-89. doi:10.1017/S0954579401003042
85. Keshavan MS, Diwadkar V, Rosenberg DR. Developmental biomarkers in schizophrenia and other psychiatric disorders: common origins, different trajectories? Epidemiol Psichiatr Soc (2005) 14:188-93. doi:10.1017/S1121189X00007934
86. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci (2008) 9:947-57. doi:10.1038/nrn2513
87. Ballon JS, Kaur T, Marks I, Cadenhead KS. Social functioning in young people at risk for schizophrenia. Psychiatry Res (2007) 151:29-35. doi:10.1016/j.psychres.2006.10.012
88. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res (1999) 33:513-21. doi:10.1016/S0022-3956(99)00033-3
89. Cannon TD, Van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, et al. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 29:653-69. doi:10.1093/oxfordjournals.schbul.a007037
90. Tan HY, Callicott JH, Weinberger DR. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex (2007) 17(Suppl 1):i171-81. doi:10.1093/cercor/bhm069
91. Gore CD, Banyai M, Gray PJ, Diwadkar V, Erdi P. Pathological effects of cortical architecture on working memory in schizophrenia. Pharmacopsychiatry (2010) 43(Suppl 1):S92-7. doi:10.1055/s-0030-1251979
92. Posner MI. Imaging attention networks. Neuroimage (2012) 61:450-6. doi:10.1016/j.neuroimage.2011.12.040
93. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 174:3-16. doi:10.1007/s00213-004-1793-y
94. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci (2007) 10:376-84. doi:10.1038/nn1846
95. Diwadkar VA, Pruitt P, Zhang A, Radwan J, Keshavan MS, Murphy E, et al. The neural correlates of performance in adolescents at risk for schizophrenia: inefficiently increased cortico-striatal responses measured with fMRI. J Psychiatr Res (2012) 46:12-21. doi:10.1016/j.jpsychires.2011.09.016
96. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 10:1078-92. doi:10.1093/cercor/10.11.1078
97. Jansma JM, Ramsey NF, Van Der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 68:159-71. doi:10.1016/S0920-9964(03)00127-0
98. Walton E, Geisler D, Lee PH, Hass J, Turner JA, Liu J, et al. Prefrontal inefficiency is associated with polygenic risk for schizophrenia. Schizophr Bull (2013). doi:10.1093/schbul/sbt174
99. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci (2001) 2:417-24. doi:10.1038/35077500
100. Bakshi N, Pruitt P, Radwan J, Keshavan MS, Rajan U, Zajac-Benitez C, et al. Inefficiently increased anterior cingulate modulation of cortical systems during working memory in young offspring of schizophrenia patients. J Psychiatr Res (2011) 45:1067-76. doi:10.1016/j.jpsychires.2011.01.002
101. Diwadkar VA, Bakshi N, Gupta G, Pruitt P, White R, Eickhoff SB, et al. Dysfunction and disconnection in cortical-striatal networks during sustained attention: genetic risk for schizophrenia or bipolar disorder and its impact on brain network function. Front Psychiatry (2014) 5:50. doi:10.3389/fpsyt.2014.00050
102. Friston KJ. Models of brain function in neuroimaging. Annu Rev Psychol (2005) 56:57-87. doi:10.1146/annurev.psych.56.091103.070311
103. Diwadkar VA, Wadehra S, Pruitt P, Keshavan MS, Rajan U, Zajac-Benitez C, et al. Disordered cortico-limbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by fMRI and dynamic causal modeling. Arch Gen Psychiatry (2012) 69:231-42. doi:10.1001/archgenpsychiatry.2011.1349
104. Cohen AS, Docherty NM, Nienow T, Dinzeo T. Self-reported stress and the deficit syndrome of schizophrenia. Psychiatry (2003) 66:308-16.
105. Pizzagalli DA, Oakes TR, Fox AS, Chung MK, Larson CL, Abercrombie HC, et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry (2004) 9(325):393-405. doi:10.1038/sj.mp.40014694001469
106. Soliman A, O'Driscoll GA, Pruessner J, Joober R, Ditto B, Streicker E, et al. Limbic response to psychosocial stress in schizotypy: a functional magnetic resonance imaging study. Schizophr Res (2011) 131:184-91. doi:10.1016/j.schres.2011.05.016
107. Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. Am J Psychiatry (2012) 169:364-73. doi:10.1176/appi.ajp.2011.11030447
108. Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol (2011) 11:625-32. doi:10.1038/nri3042
109. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol (2008) 4:189-216. doi:10.1146/annurev.clinpsy.4.022007.141248
110. Grayson DR, Chen Y, Dong E, Kundakovic M, Guidotti A. From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia. Epigenetics (2009) 4:144-9. doi:10.4161/epi.4.3.8534
111. Grayson DR. Schizophrenia and the epigenetic hypothesis. Epigenomics (2010) 2:341-4. doi:10.2217/epi.10.22
112. Grayson DR, Guidotti A. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2013) 38:138-66. doi:10.1038/npp.2012.125
113. Van Speybroeck L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann N Y Acad Sci (2002) 981:61-81. doi:10.1111/j.1749-6632.2002.tb04912.x
114. Serafini G, Pompili M, Innamorati M, Giordano G, Montebovi F, Sher L, et al. The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior. Neurosci Res (2012) 73:179-90. doi:10.1016/j.neures.2012.04.001
115. Lett TA, Chakavarty MM, Felsky D, Brandl EJ, Tiwari AK, Goncalves VF, et al. The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry (2013) 18:443-50. doi:10.1038/mp.2013.17
116. Cross-Disorder Group of the Psychiatric Genomics Lee C, Ripke SH, Neale S, Faraone BM, Purcell SV, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 45:984-94. doi:10.1038/ng.2711
117. Rutter M, Moffit TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry (2006) 47:226-61. doi:10.1111/j.1469-7610.2005.01557.x
118. D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 259:413-31. doi:10.1007/s00406-009-0024-2
119. Gonzalez-Burgos G, Hashimoto T, Lewis DA. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 12:335-44. doi:10.1007/s11920-010-0124-8
120. Yang X, Ewald ER, Huo Y, Tamashiro KL, Salvatori R, Sawa A, et al. Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5. Biochem Biophys Res Commun (2012) 420:570-5. doi:10.1016/j.bbrc.2012.03.035
121. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2013) 16:33-41. doi:10.1038/nn.3275
122. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey A, Willour VL, et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology (2010) 151:4332-43. doi:10.1210/en.2010-0225
123. Lee RS, Tamashiro KL, Yang X, Purcell RH, Huo Y, Rongione M, et al. A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl) (2011) 218:303-12. doi:10.1007/s00213-011-2307-3
124. Mehta D, Binder EB. Gene x environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology (2012) 62:654-62. doi:10.1016/j.neuropharm.2011.03.009
125. Aas M, Dazzan P, Mondelli V, Melle I, Murray RM, Pariante CM. A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation. Front Psychiatry (2014) 4:182. doi:10.3389/fpsyt.2013.00182
126. Menne-Lothmann C, Jacobs N, Derom C, Thiery E, Van Os J, Wichers M. Genetic and environmental causes of individual differences in daily life positive affect and reward experience and its overlap with stress-sensitivity. Behav Genet (2012) 42:778-86. doi:10.1007/s10519-012-9553-y
127. Morris MC, Ciesla JA, Garber J. A prospective study of stress autonomy versus stress sensitization in adolescents at varied risk for depression. J Abnorm Psychol (2010) 119:341-54. doi:10.1037/a0019036
128. Collip D, Habets P, Marcelis M, Gronenschild E, Lataster T, Lardinois M, et al. Hippocampal volume as marker of daily life stress sensitivity in psychosis. Psychol Med (2012) 43(7):1377-87. doi:10.1017/S003329171200219X
129. Zimmerman EC, Bellaire M, Ewing SG, Grace AA. Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia. Neuropsychopharmacology (2013) 38:2131-9. doi:10.1038/npp.2013.110
130. Federenko IS, Schlotz W, Kirschbaum C, Bartels M, Hellhammer DH, Wust S. The heritability of perceived stress. Psychol Med (2006) 36:375-85. doi:10.1017/S0033291705006616
131. Bogdan R, Pizzagalli DA. The heritability of hedonic capacity and perceived stress: a twin study evaluation of candidate depressive phenotypes. Psychol Med (2009) 39:211-8. doi:10.1017/S0033291708003619
132. Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry (2014) 4:e365. doi:10.1038/tp.2014.8
133. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci (2004) 7:847-54. doi:10.1038/nn1276nn1276
134. Piazza PV, Barrot M, Rouge-Pont F, Marinelli M, Maccari S, Abrous DN, et al. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Natl Acad Sci U S A (1996) 93:15445-50. doi:10.1073/pnas.93.26.15445
135. Goel N, Bale TL. Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology (2010) 151:1784-94. doi:10.1210/en.2009-1180
136. Hanna GL, Yuwiler A, Cantwell DP. Whole blood serotonin in juvenile obsessive-compulsive disorder. Biol Psychiatry (1991) 29:738-44. doi:10.1016/0006-3223(91)90193-P
137. Sallee FR, Richman H, Beach K, Sethuraman G, Nesbitt L. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry (1996) 35:1647-56. doi:10.1097/00004583-199612000-00017
138. Delorme R, Betancur C, Callebert J, Chabane N, Laplanche JL, Mouren-Simeoni MC, et al. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder. Neuropsychopharmacology (2005) 30:1539-47. doi:10.1038/sj.npp.1300752
139. Wang D, Szyf M, Benkelfat C, Provencal N, Turecki G, Caramaschi D, et al. Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One (2012) 7:e39501. doi:10.1371/journal.pone.0039501
140. Shumay E, Logan J, Volkow ND, Fowler JS. Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men. Epigenetics (2012) 7:1151-60. doi:10.4161/epi.21976
141. Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A, et al. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci (2011) 31:6692-8. doi:10.1523/JNEUROSCI.6631-10.2011
142. Koenen KC, Uddin M, Chang SC, Aiello AE, Wildman DE, Goldmann E, et al. SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety (2011) 28(8):639-47. doi:10.1002/da.20825
143. Jay TM, Rocher C, Hotte M, Naudon L, Gurden H, Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotox Res (2004) 6:233-44. doi:10.1007/BF03033225
144. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull (2009) 35:549-62. doi:10.1093/schbul/sbp006
145. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry (2002) 51:775-87. doi:10.1016/S0006-3223(01)01362-2
146. Hirvonen J, Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS Neurosci Ther (2011) 17:89-96. doi:10.1111/j.1755-5949.2010.00223.x
147. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics (2008) 3:97-106. doi:10.4161/epi.3.2.6034
148. Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology (2009) 34(Suppl 1):S186-95. doi:10.1016/j.psyneuen.2009.05.021
149. Wockner LF, Noble EP, Lawford BR, Young RM, Morris CP, Whitehall VL, et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry (2014) 4:e339. doi:10.1038/tp.2013.111
150. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom Med (2013) 75:523-9. doi:10.1097/PSY.0b013e3182924cf4
151. Sipahi L, Wildman DE, Aiello AE, Koenen KC, Galea S, Abbas A, et al. Longitudinal epigenetic variation of DNA methyltransferase genes is associated with vulnerability to post-traumatic stress disorder. Psychol Med (2014). doi:10.1017/S0033291714000968
152. de Jong S, Boks MPM, Fuller TF, Strengman E, Janson E, de Kovel CG, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One (2012) 7:e39498. doi:10.1371/journal.pone.0039498
153. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T, et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet (2013) 58:91-7. doi:10.1038/jhg.2012.140
154. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 20:4786-96. doi:10.1093/hmg/ddr416
155. Casey BJ, Giedd JN, Thomas KM. Structural and functional brain development and its relation to cognitive development. Biol Psychol (2000) 54:241-57.
156. Casey BJ, Galvan A, Hare TA. Changes in cerebral functional organization during cognitive development. Curr Opin Neurobiol (2005) 15:239-44. doi:10.1016/j.conb.2005.03.012
157. Stephan KE, Roebroeck A. A short history of causal modeling of fMRI data. Neuroimage (2012) 62:856-63. doi:10.1016/j.neuroimage.2012.01.034
158. McNamara RK, Strawn JR, Chang KD, Delbello MP. Interventions for youth at high risk for bipolar disorder and schizophrenia. Child Adolesc Psychiatr Clin N Am (2012) 21:739-51. doi:10.1016/j.chc.2012.07.009